Takao Kamai

15PUBLICATIONS
9CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Apr 11, 2025
Tertiary Lymphoid Structures Correlate With Better Prognosis in Patients With Retroperitoneal Sarcoma: A Retrospective Study.

Toshiki Kijima, Atsuko Takada-Owada, Hidetoshi Kokubun

|Jan 29, 2025
Predictive role of ABC transporters in the efficacy of enfortumab vedotin for urothelial carcinoma.

Toshiki Kijima, Atsuko Takada-Owada, Hiroki Shimoda

|Mar 05, 2024
Increased expression of ATP-binding cassette transporters in enfortumab vedotin-resistant urothelial cancer.

Mariko Kotono, Toshiki Kijima, Atsuko Takada-Owada

|Mar 05, 2024
A patient with oligometastatic hormone-sensitive prostate cancer who achieved long-term progression-free survival following cytoreductive radical prostatectomy and metastasectomy.

Daisuke Mamiya, Toshiki Kijima, Atsuko Takada-Owada

|Dec 19, 2023
Summary of the Clinical Practice Guidelines for Upper Tract Urothelial Carcinoma 2023 by the Japanese Urological Association.

Kazuyuki Mori, Shingo Hatakeyama, Hideki Enokida

|Nov 06, 2023
A case of adrenal undifferentiated pleomorphic sarcoma with tertiary lymphoid structures responded to pembrolizumab.

Hidetoshi Kokubun, Toshiki Kijima, Atsuko Takada-Owada

Pageof 3

Frequent Collaborators

8 joint publications

Toshiki Kijima

1 joint publications

Minoru Kobayashi

1 joint publications

Akinori Nukui

1 joint publications

Shingo Hatakeyama